✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Unjha Formulations Ltd.

UNJHAFOR

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹11 Cr.
P/E
116.58

Unjha Formulations Ltd.

  • Unjha Formulations
  • Decipher Labs
  • Cian Healthcare
FAQs on Unjha Formulations Ltd. Shareprice

Unjha Formulations has given better returns compared to its competitors.
Unjha Formulations has grown at ~24.95% over the last 6yrs while peers have grown at a median rate of 10.2%

Yes, Unjha Formulations is expensive.
Latest PE of Unjha Formulations is 116, while 3 year average PE is 25.84.
Also latest EV/EBITDA of Unjha Formulations is 32.89 while 3yr average is 25.21.

View FAQ's On Business
Growth Table
  • Unjha Formulations Ltd.
  • Decipher Labs
  • Cian Healthcare
Balance Sheet
  • Unjha Formulations Ltd.
  • Decipher Labs
  • Cian Healthcare
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Unjha Formulations Ltd.
  • Decipher Labs
  • Cian Healthcare
Cash Flow
  • Unjha Formulations Ltd.
  • Decipher Labs
  • Cian Healthcare
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Unjha Formulations Ltd.
  • Decipher Labs
  • Cian Healthcare
Quarterly Results
  • Unjha Formulations Ltd.
  • Decipher Labs
  • Cian Healthcare
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Unjha Formulations Ltd. Financials

Balance sheet of Unjha Formulations is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Unjha Formulations is increasing.
Latest net debt of Unjha Formulations is -₹1.29 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹1.75 Crs.

The profit is oscillating.
The profit of Unjha Formulations is ₹0.41 Crs for Mar 2025, ₹0.28 Crs for Mar 2024 and ₹0.28 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Unjha Formulations latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech